TY  - CHAP
M1  - Book, Section
TI  - Chapter 354. Toxoplasmosis
A1  - Saux, Nicole M. A. Le
A2  - Rudolph, Colin D.
A2  - Rudolph, Abraham M.
A2  - Lister, George E.
A2  - First, Lewis R.
A2  - Gershon, Anne A.
Y1  - 2011
N1  - 
T2  - Rudolph's Pediatrics, 22e
AB  - It  is  estimated  that  500  million  people  worldwide  are  infected  with  Toxoplasma  gondii.1  Seroprevalence  studies  have  uniformly  indicated  increasing  rates  with  age  (eFig.  354.1).  Between  1999  and  2004,  the  age-adjusted  T.  gondii  seroprevalence  rate  declined  from  14.1%  to  9%  among  U.S.-born  persons  ages  12  to  49  years.2  The  rates  varied  among  regions,  probably  due  to  differing  climates,  culinary  practices,  and  immigration  patterns  from  areas  of  the  world  that  have  higher  endemic  rates  of  Toxoplasma  infections.  Data  from  Europe  generally  indicates  a  slightly  higher  prevalence  rate  compared  to  the  United  States,  with  rates  in  Central  Europe  ranging  from  24%  in  Greece  to  41%  in  France  and  Poland.3-5  In  the  United  States,  seroprevalence  rates  in  women  of  childbearing  age  are  approximately  15%,  whereas  rates  in  similar  populations  from  western  Europe,  Africa,  and  Central  and  South  America  are  greater  than  50%.1,6  The  general  population  of  blood  donors  from  Turkey  was  found  to  have  a  20%  seroprevalence  rate,  while  the  seroprevalence  restricted  to  women  was  found  to  be  relatively  high  at  52.1%.7,8  In  the  last  two  decades,  most  European  countries  have  noted  a  decrease  in  seroprevalence  of  Toxoplasma,  possibly  due  to  less  infection  in  farm  animals,  more  filtration  of  drinking  water,  and  concerns  about  consuming  undercooked  meat.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesspediatrics.mhmedical.com/content.aspx?aid=7032232
ER  -